General Information of Drug (ID: DM6VH7A)

Drug Name
Alpha-D-Fucose Drug Info
Synonyms
Alpha-D-Fucose; alpha-D-fucopyranose; alpha-D-Fucp; 6-deoxy-alpha-D-galactopyranose; alpha-D-Fuc; UNII-K15K52FOK4; CHEBI:42564; K15K52FOK4; (2S,3R,4S,5R,6R)-6-methyloxane-2,3,4,5-tetrol; 6-Deoxy-D-galactose; Fucopyranose, alpha-D-; 6-Deoxy-alpha-D-galactose; fucoside; 1abf; 7abp; alpha-D-Galactopyranose, 6-deoxy-; 6-dideoxy galactose; AC1L9FWD; Epitope ID:115015; SCHEMBL1399668; CHEMBL609880; ZINC1532815; AKOS006272406; RP22690; DB03485; 6189-71-5; CJ-24263; F-8000; A823144; 111719-EP2371811A2; 111719-EP2275420A1; 111719-EP2298757A2
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
444200
ChEBI ID
CHEBI:42564
CAS Number
CAS 6189-71-5
TTD Drug ID
DM6VH7A

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug(s) Targeting Lactotransferrin (LTF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Parecoxib DMIV8CT N. A. N. A. Phase 4 [2]
Talactoferrin DMV7T64 Diabetic foot ulcer BD54 Phase 3 [3]
HLF 1-11 DMDFG1O Bacteremia 1A73 Phase 1/2 [4]
Nimesulide DMR1NMD Metastatic colorectal cancer 2B91 Terminated [5]
Alpha-D-Mannose DMF5DLW Discovery agent N.A. Investigative [1]
Fucose DMAHMSV N. A. N. A. Investigative [1]
Lauric Acid DM9C8KQ Discovery agent N.A. Investigative [1]
Nitrilotriacetic Acid DMIOQFU Discovery agent N.A. Investigative [1]
3h-Indole-5,6-Diol DMBFCTZ Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Lactotransferrin (LTF) TTSZDQU TRFL_HUMAN Inhibitor [1]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
3 Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study. Am J Surg. 2007 Jan;193(1):49-54.
4 The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2004 Dec;48(12):4919-21.
5 Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.